These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38944408)

  • 1. A critical appraisal of the role of metabolomics in breast cancer research and diagnostics.
    Gadwal A; Panigrahi P; Khokhar M; Sharma V; Setia P; Vishnoi JR; Elhence P; Purohit P
    Clin Chim Acta; 2024 Jul; 561():119836. PubMed ID: 38944408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic fingerprinting in breast cancer stages through
    Suman S; Sharma RK; Kumar V; Sinha N; Shukla Y
    J Pharm Biomed Anal; 2018 Oct; 160():38-45. PubMed ID: 30059813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating metabolites in the early stage of breast cancer were not related to cancer stage or subtypes but associated with ki67 level. Promising statistical discrimination from controls.
    Baranovicova E; Racay P; Zubor P; Smolar M; Kudelova E; Halasova E; Dvorska D; Dankova Z
    Mol Cell Probes; 2022 Dec; 66():101862. PubMed ID: 36162596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrative approach based on GC-qMS and NMR metabolomics data as a comprehensive strategy to search potential breast cancer biomarkers.
    Silva CL; Perestrelo R; Capelinha F; Tomás H; Câmara JS
    Metabolomics; 2021 Aug; 17(8):72. PubMed ID: 34389918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers.
    Zidi O; Souai N; Raies H; Ben Ayed F; Mezlini A; Mezrioui S; Tranchida F; Sabatier JM; Mosbah A; Cherif A; Shintu L; Kouidhi S
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33919750
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    AlMalki RH; Sebaa R; Al-Ansari MM; Al-Alwan M; Alwehaibi MA; Rahman AMA
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer detection using targeted plasma metabolomics.
    Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic studies of breast cancer in murine models: A review.
    Araújo R; Bispo D; Helguero LA; Gil AM
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165713. PubMed ID: 32014550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of metabolites and metabolic pathways in breast cancer in a Korean prospective cohort: the Korean Cancer Prevention Study-II.
    Yoo HJ; Kim M; Kim M; Kang M; Jung KJ; Hwang SM; Jee SH; Lee JH
    Metabolomics; 2018 Jun; 14(6):85. PubMed ID: 30830383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
    Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
    Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
    Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
    J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer.
    Yang Y; Zhu Y; Li X; Zhang X; Yu B
    Arch Gynecol Obstet; 2021 Jun; 303(6):1599-1606. PubMed ID: 33791842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics.
    Kus K; Kij A; Zakrzewska A; Jasztal A; Stojak M; Walczak M; Chlopicki S
    Breast Cancer Res; 2018 Dec; 20(1):148. PubMed ID: 30514398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Metabolomics Using NMR.
    Sharma U; Jagannathan NR
    Methods Mol Biol; 2019; 2037():195-213. PubMed ID: 31463847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
    Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
    Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering the metabolomic fingerprint of breast cancer.
    Oakman C; Tenori L; Biganzoli L; Santarpia L; Cappadona S; Luchinat C; Di Leo A
    Int J Biochem Cell Biol; 2011 Jul; 43(7):1010-20. PubMed ID: 20460168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary metabolite and lipid alterations in Colombian Hispanic women with breast cancer: A pilot study.
    Cala M; Aldana J; Sánchez J; Guio J; Meesters RJW
    J Pharm Biomed Anal; 2018 Apr; 152():234-241. PubMed ID: 29428809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: a first approach for breast cancer.
    Silva CL; Perestrelo R; Silva P; Tomás H; Câmara JS
    Metabolomics; 2019 Apr; 15(4):64. PubMed ID: 30997581
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.